Under Pressure: Sanofi's Strategy Will Be Tested By Generic Lovenox Approval

Ahead of the big pharma's earnings call July 29, Sanofi-Aventis is under renewed pressure with Momenta and partner Sandoz promising a swift launch of their newly approved generic version of Lovenox.